A
APLS

AlphaQuest’s Apellis Pharmaceuticals APLS Stock Holding History

AlphaQuest’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,741
Closed -$295K – 142
2025
Q4 		$295K Sell
11,741
-11,358
-49% -$266K 0.02% 1223
2025
Q3 		$523K Buy
23,099
+1,859
+9% +$43.4K 0.03% 771
2025
Q2 		$368K Sell
21,240
-34,864
-62% -$645K 0.04% 768
2025
Q1 		$1.23M Buy
56,104
+38,918
+226% +$1.08M 0.13% 233
2024
Q4 		$548K Buy
17,186
+16,976
+8,084% +$511K 0.07% 442
2024
Q3 		$6.06K Buy
+210
New +$7.78K ﹤0.01% 1575
2024
Q2 		– Sell
-1
Closed -$59 – 1572
2024
Q1 		$59 Buy
+1
New +$64 ﹤0.01% 1607

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AlphaQuest's APLS Position: Q1 2026 in Review

AlphaQuest sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 11,741 shares — an estimated $295K sold.

AlphaQuest first reported a position in APLS in Q1 2024 and held it in 7 quarters. The position peaked at $1.23M in Q1 2025. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • AlphaQuest reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 11,741 Apellis Pharmaceuticals shares in Q1 2026, an estimated $295K.
  • AlphaQuest first reported a position in Apellis Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • AlphaQuest's Apellis Pharmaceuticals position peaked at $1.23M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.